Ładuje się......
Engineering Oncolytic Vaccinia Virus to redirect Macrophages to Tumor Cells
Oncolytic virotherapy has been tested in numerous early phase clinical studies. However, the antitumor activity of oncolytic viruses thus far has been limited. Numerous strategies are being explored to enhance their antitumor activity by activating the adaptive arm of the immune system. We reasoned...
Zapisane w:
| Wydane w: | Adv Cell Gene Ther |
|---|---|
| Główni autorzy: | , , , , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8021125/ https://ncbi.nlm.nih.gov/pubmed/33829146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acg2.99 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|